CLDN8 Antikörper (AA 140-166)
Kurzübersicht für CLDN8 Antikörper (AA 140-166) (ABIN653170)
Target
Alle CLDN8 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- AA 140-166
-
Aufreinigung
- This antibody is purified through a protein A column, followed by peptide affinity purification.
-
Immunogen
- This CLDN8 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 140-166 amino acids from the Central region of human CLDN8.
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
- WB: 1:1000. FC: 1:10~50
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Buffer
- Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Maintain refrigerated at 2-8 °C for up to 6 months. For long term storage store at -20 °C in small aliquots to prevent freeze-thaw cycles.
-
Haltbarkeit
- 6 months
-
-
-
: "Claudin 8 Contributes to Malignant Proliferation in Human Osteosarcoma U2OS Cells." in: Cancer biotherapy & radiopharmaceuticals, Vol. 30, Issue 9, pp. 400-4, (2015) (PubMed).
-
: "Claudin 8 Contributes to Malignant Proliferation in Human Osteosarcoma U2OS Cells." in: Cancer biotherapy & radiopharmaceuticals, Vol. 30, Issue 9, pp. 400-4, (2015) (PubMed).
-
- CLDN8 (Claudin 8 (CLDN8))
-
Andere Bezeichnung
- CLDN8
-
Hintergrund
- CLDN8 is components of epithelial cell tight junctions. Tight junctions regulate movement of solutes and ions through the paracellular space and prevent mixing of proteins and lipids in the outer leaflet of the apical and basolateral plasma membrane domains
-
Molekulargewicht
- 24845
-
Gen-ID
- 9073
-
NCBI Accession
- NP_955360
-
UniProt
- P56748
-
Pathways
- Hepatitis C
Target
-